Doxazosin Discontinuation Guidelines

Introduction to Doxazosin Discontinuation

Doxazosin should not be stopped abruptly, especially in patients taking it for hypertension, as this could potentially lead to rebound effects, according to the American College of Cardiology and the American Heart Association 1, 2
Alpha-1 blockers like doxazosin are associated with specific discontinuation concerns, and the guidelines for doxazosin are less explicit compared to central alpha-2 agonists, as noted by the American Heart Association 1, 2, 3

The American College of Cardiology and the American Heart Association recommend avoiding abrupt cessation for beta blockers, but do not make the same explicit recommendation for alpha blockers, highlighting the need for careful consideration in doxazosin discontinuation 4
A gradual taper is prudent, especially in patients with difficult-to-control hypertension, and blood pressure should be monitored closely during the discontinuation period, as suggested by clinical guidelines 1, 2

Elderly patients may be more susceptible to hemodynamic changes, and patients with comorbid conditions, such as cardiovascular disease or orthostatic hypotension, require closer monitoring during doxazosin discontinuation, according to clinical recommendations 1, 2
For maximum safety, a conservative approach would be to taper doxazosin over 1-2 weeks rather than stopping it abruptly, particularly in patients with difficult-to-control hypertension, multiple antihypertensive medications, history of cardiovascular disease, or elderly status, as advised by the American College of Cardiology 1, 2